PubMed COVID-19 Clinical Care

CONCLUSION: The utilization of a pharmacy consult service has facilitated interdisciplinary team collaboration and ultimately empowered the utilization of oral COVID-19 therapy.

Estimates of the prevalence of long COVID vary widely. This retrospective cohort study describes the incidence of long COVID symptoms 12-20 weeks post-diagnosis in a US ambulatory care setting and identifies potential risk factors. We identified

SARS-CoV-2 vaccine protection has encountered waning of immune response and breakthrough infections. The hybrid immune response generated by the combination of vaccination and infection was shown to offer higher and broader protection. Here, we

CONCLUSION: These data suggest localised discrete loss of lung units in approximately half of long COVID patients, not completely explained by loss of V (A) or of alveolar-capillary recruitment during exercise.

Viruses with an RNA genome are often the cause of zoonotic infections. In order to identify novel pro-viral host cell factors, we screened a haploid insertion-mutagenized mouse embryonic cell library for clones that are resistant to Rift Valley fever

Despite reduced resting lung volumes and D (LCO), patients with long COVID and dyspnoea have similar physiological response to exercise to healthy subjects. D (LCO) impairment can marginally explain heterogeneity of complex syndromes such as long

Health economics seek to provide the information which can contribute to the rational decision making, towards the appropriate allocation of scarce healthcare resources. Through the COVID-19 pandemic, everyone has recognized that healthcare resource

CONCLUSION: Fear of COVID-19 can be one of the primary contributors to worsening insomnia.

Individuals with weaker neutralizing responses show reduced protection with SARS-CoV-2 variants. Booster vaccines are recommended for vaccinated individuals, but the uptake is low. We present the feasibility of utilizing point-of-care tests (POCT) to

CONCLUSION: Muscle disability and lung dysfunction are common in COVID-19 survivors. Hospitalization was associated with the worst muscle force and diffusing capacity of the lung for carbon monoxide. Computed tomography characteristics could be a